Abbott New Generation Hemolytic 1700 System - Taiwan Registration 25e8a6fa5af29318f21b9a5424a37eca
Access comprehensive regulatory information for Abbott New Generation Hemolytic 1700 System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 25e8a6fa5af29318f21b9a5424a37eca and manufactured by ABBOTT LABORATORIES. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Limited to the first level identification range of red blood cell dissolving agent (B.8540) of the Measures for the Administration of Medical Devices.
B Hematology, pathology, and genetics
B.8540 ็ด ่ก็ๆบถ่งฃๅ
import
Dates and Status
Oct 22, 2010
Oct 22, 2015
Aug 09, 2018
Cancellation Information
Logged out
ๆชๅฑๅปถ่้พๆ่